| Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience D Vallisa, P Bernuzzi, L Arcaini, S Sacchi, V Callea, R Marasca, ... Journal of Clinical Oncology 23 (3), 468-473, 2005 | 319 | 2005 |
| R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana … M Federico, S Luminari, A Dondi, A Tucci, U Vitolo, L Rigacci, ... Journal of Clinical Oncology 31 (12), 1506-1513, 2013 | 316 | 2013 |
| Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients S Sacchi, HM Kantarjian, S O'Brien, J Cortes, MB Rios, FJ Giles, M Beran, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1999 | 245 | 1999 |
| Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. KH sacchi s | 201* | |
| Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study S Sacchi, L Marcheselli, A Bari, R Marcheselli, S Pozzi, S Luminari, ... Haematologica 93 (3), 398-404, 2008 | 129 | 2008 |
| Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients S Pozzi, R Marcheselli, S Sacchi, L Baldini, F Angrilli, E Pennese, ... Leukemia & lymphoma 48 (1), 56-64, 2007 | 124 | 2007 |
| Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease A Tedeschi, G Benevolo, M Varettoni, ML Battista, PL Zinzani, C Visco, ... Cancer 118 (2), 434-443, 2012 | 123 | 2012 |
| Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story A Bari, L Marcheselli, S Sacchi, R Marcheselli, S Pozzi, P Ferri, E Balleari, ... Annals of Oncology 21 (7), 1486-1491, 2010 | 120 | 2010 |
| Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma S Sacchi, M Federico, U Vitolo, C Boccomini, D Vallisa, L Baldini, ... haematologica 86 (9), 951-958, 2001 | 104 | 2001 |
| Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study G D'arena, PG Gobbi, C Broglia, S Sacchi, G Quarta, L Baldini, E Iannitto, ... Leukemia & lymphoma 52 (5), 771-775, 2011 | 103 | 2011 |
| Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population‐based analysis S Pozzi, L Marcheselli, A Bari, EV Liardo, R Marcheselli, S Luminari, ... British journal of haematology 163 (1), 40-46, 2013 | 102 | 2013 |
| Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysis M Pirani, R Marcheselli, L Marcheselli, A Bari, M Federico, S Sacchi Annals of Oncology 22 (8), 1845-1858, 2011 | 96 | 2011 |
| Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre-and post … T Tadmor, A Bari, S Sacchi, L Marcheselli, EV Liardo, I Avivi, N Benyamini, ... haematologica 99 (1), 125, 2014 | 95 | 2014 |
| Diagnosis of essential thrombocythemia at platele counts between 400 and 600x10 (9)/L. S Sacchi, G Vinci, L Gugliotta, S Rupoli, L Gargantini, V Martinelli, ... Haematologica 85, 492-495, 2000 | 76 | 2000 |
| Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab S Sacchi, M Federico, G Dastoli, C Fiorani, G Vinci, V Clò, B Casolari Critical reviews in oncology/hematology 37 (1), 13-25, 2001 | 74 | 2001 |
| Bcl-2 oncoprotein expression in acute myeloid leukemia L Bensi, R Longo, A Vecchi, C Messora, L Garagnani, S Bernardi, ... Haematologica 80 (2), 98-102, 1995 | 74 | 1995 |
| Introduction of rituximab in front‐line and salvage therapies has improved outcome of advanced‐stage follicular lymphoma patients S Sacchi, S Pozzi, L Marcheselli, A Bari, S Luminari, F Angrilli, F Merli, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 66 | 2007 |
| Cytogenetic conversion in a case of polycythaemia vera treated with interferon‐alpha C Messora, L Bensi, A Vecchi, R Longo, F Giacobbi, P Temperani, ... British journal of haematology 86 (2), 402-404, 1994 | 62 | 1994 |
| Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki‐67 and anti‐bromo‐deoxyuridine … B Falini, S Canino, S Sacchi, C Ciani, MF Martelli, J Gerdes, H Stein, ... British journal of haematology 69 (3), 311-320, 1988 | 61 | 1988 |
| Neutrophil‐lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving … R Marcheselli, A Bari, T Tadmor, L Marcheselli, MC Cox, S Pozzi, ... Hematological oncology 35 (4), 561-566, 2017 | 59 | 2017 |
